Enzo Biochem Reports Fiscal First Quarter Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Enzo Biochem Reports Fiscal First Quarter Results

Enzo Biochem (ENZ) Reports Q1 Loss of $0.13

December 10, 2019 4:18 PM EST

Enzo Biochem (NYSE: ENZ) reported Q1 EPS of ($0.13), versus ($0.13) reported last year. Revenue for the quarter came in at $20.2 million versus the consensus estimate of $20.92 million.

Elazar Rabbani, PhD., Chairman and Chief Executive Officer, Comment:

We continue to be intently focused on creating the new model of a modern day diagnostics company. Our goals remain to develop and validate platforms focused on high-value areas that can reduce costs 30-50% and satisfy clinical demand for fully automated platforms and products while retaining an attractive profit margin for Enzo. This has required investment in our dynamic vertically... More